Why 90% of clinical drug development fails and how to improve it?

Duxin Sun; Wei Gao; Hongxiang Hu; Simon Zhou

doi:10.1016/j.apsb.2022.02.002

Keywords

PotencyDrugPharmacologyDrug developmentToxicityEfficacyMedicineClinical efficacyChemistryInternal medicineIn vitroBiochemistry

Affiliated Institutions

Related Publications

Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics

William E. Evans , Mary V. Relling

Genetic polymorphisms in drug-metabolizing enzymes, transporters, receptors, and other drug targets have been linked to interindividual differences in the efficacy and toxicity ...

1999 Science 2463 citations

<i>In silico</i>pharmacology for drug discovery: applications to targets and beyond

Sean Ekins , Jordi Mestres , Bernard Testa

Computational ( in silico ) methods have been developed and widely applied to pharmacology hypothesis development and testing. These in silico methods include databases, quantit...

2007 British Journal of Pharmacology 343 citations

Lack of a Clinically Significant Pharmacokinetic Interaction between Fenofibrate and Pravastatin in Healthy Volunteers

Wei‐Jian Pan , Linda E. Gustavson , Ramanuj Achari +4 more

This study was conducted to evaluate the potential pharmacokinetic interaction between fenofibrate and pravastatin. A total of 23 healthy adult volunteers received single‐dose 2...

2000 The Journal of Clinical Pharmacology 91 citations

ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties

Guo‐Li Xiong , Zhenhua Wu , Jiacai Yi +10 more

Abstract Because undesirable pharmacokinetics and toxicity of candidate compounds are the main reasons for the failure of drug development, it has been widely recognized that ab...

2021 Nucleic Acids Research 2290 citations

Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation

Jeffrey L. Anderson , Benjamin D. Horne , Scott M. Stevens +8 more

Background— Pharmacogenetic-guided dosing of warfarin is a promising application of “personalized medicine” but has not been adequately tested in randomized trials. Methods and ...

2007 Circulation 727 citations

Publication Info

Year: 2022
Type: review
Volume: 12
Issue: 7
Pages: 3049-3062
Citations: 1262
Access: Closed

External Links